OBJECTIVE: To examine factors related to older primary care patients' willingness to consider tapering/discontinuation of long-term benzodiazepine use. METHOD: Forty-six long-term anxiolytic benzodiazepine users, aged 61-95 years, were assessed over the telephone using a semi-structured qualitative interview and standardized self-report questionnaires for anxiety (Beck Anxiety Inventory), sleep quality (Pittsburgh Sleep Quality Index), depression (Center for Epidemiological Studies Depression Scale), psychological dependence on benzodiazepines (Severity of Dependence Scale), and anxiety sensitivity (Anxiety Sensitivity Index). RESULTS: Frequency of daily benzodiazepine intake and anxiety sensitivity significantly contributed to willingness to attempt taper/discontinuation of benzodiazepines. CONCLUSION: Many older long-term benzodiazepine users and their physicians perceive tapering of use an arduous, low priority, time-intensive task. These findings highlight factors that can help identify a subpopulation of older patients who may be easier to engage in the discontinuation process.
OBJECTIVE: To examine factors related to older primary care patients' willingness to consider tapering/discontinuation of long-term benzodiazepine use. METHOD: Forty-six long-term anxiolytic benzodiazepine users, aged 61-95 years, were assessed over the telephone using a semi-structured qualitative interview and standardized self-report questionnaires for anxiety (Beck Anxiety Inventory), sleep quality (Pittsburgh Sleep Quality Index), depression (Center for Epidemiological Studies Depression Scale), psychological dependence on benzodiazepines (Severity of Dependence Scale), and anxiety sensitivity (Anxiety Sensitivity Index). RESULTS: Frequency of daily benzodiazepine intake and anxiety sensitivity significantly contributed to willingness to attempt taper/discontinuation of benzodiazepines. CONCLUSION: Many older long-term benzodiazepine users and their physicians perceive tapering of use an arduous, low priority, time-intensive task. These findings highlight factors that can help identify a subpopulation of older patients who may be easier to engage in the discontinuation process.
Authors: Marcia Valenstein; Kiran Khanujua Taylor; Karen Austin; Helen C Kales; John F McCarthy; Frederic C Blow Journal: Am J Psychiatry Date: 2004-04 Impact factor: 18.112
Authors: R Kathryn McHugh; Victoria R Votaw; Olivera Bogunovic; Sterling L Karakula; Margaret L Griffin; Roger D Weiss Journal: Addict Behav Date: 2016-08-18 Impact factor: 3.913
Authors: Rachel D Maree; Zachary A Marcum; Ester Saghafi; Debra K Weiner; Jordan F Karp Journal: Am J Geriatr Psychiatry Date: 2016-06-07 Impact factor: 4.105
Authors: David J Allsop; Jan Copeland; Melissa M Norberg; Shanlin Fu; Anna Molnar; John Lewis; Alan J Budney Journal: PLoS One Date: 2012-09-26 Impact factor: 3.240
Authors: Joachim Marti; Marcus Bachhuber; Jordyn Feingold; David Meads; Michael Richards; Sean Hennessy Journal: BMJ Open Date: 2017-10-06 Impact factor: 2.692